Prevention of peritoneal adhesions with aprotinin (trasylol).
An objective assessment of intraperitoneal trasylol in the prevention of abdominal adhesions in 20 patients has shown that Trasylol resulted in a marked reduction in adhesions in 16 patients who underwent 'second look' procedures. No side-effects were noted and all wounds healed without complications.